Ribitol (Adonitol)是一种戊糖醇结晶,通过核糖还原形成,在Adonis vernalis植物中自然发生。Ribitol是一种戊糖醇结晶,从Adonis vernalis这种植物中鉴定出来的 。在10% NFSM悬浮液中的Ribitol是相同浓度甘油保护效果的 1.45到 2.18倍。0.75 M Ribitol的抗冻效果最高。
Ribitol is a crystalline pentose alcohol and is formed by the reduction of ribose which is occurs naturally in the plant Adonis vernalis.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Negm FB, et al. Plant Physiol. 1985, 78(4), 758-761.
[2] Toivari MH, et al. Enhancing the flux of D-glucose to the pentose phosphate pathway in Saccharomyces cerevisiae for the production of D-ribose and ribitol. Appl Microbiol Biotechnol. 2010 Jan;85(3):731-9.
分子式 C5H12O5 |
分子量 152.15 |
CAS号 488-81-3 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 33 mg/mL, |
Water 33 mg/mL, |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT02139228 | Meningitis, Epiglottitis, Pneumonia, Arthritis Caused by Haemophilus Influenzae Type b | Biological: Hib-CRM197|Biological: Hib-TT | Novartis Vaccines|Novartis | Phase 3 | 2014-11-01 | 2015-10-13 |
NCT01226953 | Haemophilus Influenzae Type b (Hib) Infection | Biological: Haemophilus influenzae type b (Hib) vaccine | Novartis Vaccines|Novartis | Phase 3 | 2010-10-01 | 2011-12-27 |
NCT01357720 | Diphtheria|Pertussis|Tetanus|Hepatitis B|Haemophilus Infections | Biological: Quinvaxem|Biological: Quinvaxem/Tritanrix | Crucell Holland BV | Phase 4 | 2011-05-01 | 2013-08-29 |
NCT01917357 | Diphtheria|Pertussis|Tetanus|Hepatitis B|Haemophilus Infections | Biological: Quinvaxem in Uniject|Biological: Quinvaxem in single dose vials | Crucell Holland BV | Phase 3 | 2013-09-01 | 2014-07-12 |
NCT01062477 | Diphtheria|Tetanus|Pertussis|Haemophilus Influenzae Type B | Biological: DTaP//PRP-T Combined Vaccine|Biological: DTaP//PRP-T Combined Vaccine|Biological: DTaP Combined Vaccine and PRP-Tetanus Conjugate Vaccine | Sanofi | Phase 3 | 2010-01-01 | 2011-12-12 |
NCT02853929 | Diphtheria|Hepatitis B|Acellular Pertussis|Haemophilus Influenzae Type b|Tetanus|Poliomyelitis | Biological: Infanrix hexa | GlaxoSmithKline | Phase 4 | 2016-09-01 | 2017-03-21 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们